Cord blood is a rich source of newborn stem cells that has over the last 30 years been used in successful FDA-approved treatments for more than 80 serious diseases to replace damaged blood and immune systems with healthy cells.
As cord blood stem cell research advances, so does the potential for future uses. Experimental therapies that may not have seemed possible 20 years ago are being explored today in FDA regulated clinical trials. Regenerative medicine is revolutionary field of medicine that aims to replace, repair, and regenerate human cells, tissues, or organs lost or injured due to age, disease, or congenital defects to restore or establish normal function in areas of research within regenerative medicine:
Each day, we learn more about stem cells and their role in regenerative medicine. Current studies and clinical trials are fueling research into new applications for the future, so the possibilities for your family are endless. These trials represent a new, exciting age in umbilical cord blood and tissue research. It’s estimated that 1 in 3 people will benefit from regenerative medicine in their lifetime.
For over two decades, CellSave has worked with
hundreds of thousands of families to preserve their
newborn’s valuable stem cells through cord blood
and tissue banking. Take advantage of this once-in-a-lifetime opportunity and join the CellSave family today!
